BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: DeWitt-Foy ME, Nickel JC, Shoskes DA. Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Eur Urol Focus 2019;5:2-4. [PMID: 30206001 DOI: 10.1016/j.euf.2018.08.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen CH, Tyagi P, Chuang YC. Promise and the Pharmacological Mechanism of Botulinum Toxin A in Chronic Prostatitis Syndrome. Toxins (Basel) 2019;11:E586. [PMID: 31614473 DOI: 10.3390/toxins11100586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dashdondov O, Wazir J, Sukhbaatar G, Mikrani R, Dorjsuren B, Aktar N, Zhou X. Herbal nutraceutical treatment of chronic prostatitis-chronic pelvic pain syndrome: a literature review. Int Urol Nephrol 2021;53:1515-28. [PMID: 33907984 DOI: 10.1007/s11255-021-02868-w] [Reference Citation Analysis]
3 Moryousef J, Blankstein U, Curtis Nickel J, Krakowsky Y, Gilron I, Jarvi K. Overview of seminal fluid biomarkers for the evaluation of chronic prostatitis: a scoping review. Prostate Cancer Prostatic Dis 2021. [PMID: 34845305 DOI: 10.1038/s41391-021-00472-8] [Reference Citation Analysis]
4 Mishra V. Re: Gregory W. Hosier, Thomas McGregor, Darren Beiko, et al. Persistent Opioid Use Among Patients with Urolithiasis: A Population based Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.08.011. Eur Urol Focus 2021;7:898. [PMID: 32317157 DOI: 10.1016/j.euf.2020.03.007] [Reference Citation Analysis]
5 Adamian L, Urits I, Orhurhu V, Hoyt D, Driessen R, Freeman JA, Kaye AD, Kaye RJ, Garcia AJ, Cornett EM, Viswanath O. A Comprehensive Review of the Diagnosis, Treatment, and Management of Urologic Chronic Pelvic Pain Syndrome. Curr Pain Headache Rep 2020;24:27. [PMID: 32378039 DOI: 10.1007/s11916-020-00857-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Bryk DJ, Shoskes DA. Using the UPOINT system to manage men with chronic pelvic pain syndrome. Arab J Urol 2021;19:387-93. [PMID: 34552790 DOI: 10.1080/2090598X.2021.1955546] [Reference Citation Analysis]
7 Nickel JC. Chronic prostatitis/chronic pelvic pain syndrome: it is time to change our management and research strategy. BJU Int 2020;125:479-80. [DOI: 10.1111/bju.15036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zhao Q, Yang F, Meng L, Chen D, Wang M, Lu X, Chen D, Jiang Y, Xing N. Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-κB, MAPKs, and Nrf2 signaling pathways in rats. Andrology 2020;8:747-55. [PMID: 31880092 DOI: 10.1111/andr.12747] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
9 Shoskes DA, Keslar KS, Gotwald P, Berglund R, Vij S. Neuroinflammatory gene expression in chronic prostatitis/chronic pelvic pain syndrome patients: insights into etiology and phenotype biology. Transl Androl Urol 2021;10:3340-7. [PMID: 34532258 DOI: 10.21037/tau-21-387] [Reference Citation Analysis]
10 Chen J, Zhang LG, Du HX, Zhan CS, Liu Y, Zhang M, Chen XG, Wen LP, Zhang L, Liang CZ. Melatonin attenuates prostatic inflammation and pelvic pain via Sirt1-dependent inhibition of the NLRP3 inflammasome in an EAP mouse model. Prostate 2021;81:1179-90. [PMID: 34418127 DOI: 10.1002/pros.24214] [Reference Citation Analysis]
11 Chen J, Meng J, Li X, Li X, Liu Y, Jin C, Zhang L, Hao Z, Chen X, Zhang M, Liang C. HA/CD44 Regulates the T Helper 1 Cells Differentiation by Activating Annexin A1/Akt/mTOR Signaling to Drive the Pathogenesis of EAP. Front Immunol 2022;13:875412. [DOI: 10.3389/fimmu.2022.875412] [Reference Citation Analysis]